NCT03340740View on ClinicalTrials.gov

The Effect of Cetirizine on Bronchoconstriction

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 11, 2018

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions
Allergic RhinitisAsthma
Interventions
DRUG

Cetirizine Hydrochloride 1 MG/ML

Cetirizine oral suspension

DRUG

Placebo - Concentrate

Similar-appearing liquid to cetirizine oral suspension

Trial Locations (1)

10461

Jacobi Medical Center, The Bronx

All Listed Sponsors
lead

New York City Health and Hospitals Corporation

OTHER

NCT03340740 - The Effect of Cetirizine on Bronchoconstriction | Biotech Hunter | Biotech Hunter